Mary R. Tanner, M.D., from the CDC in Atlanta, and colleagues updated the 2016 nPEP guidelines and considerations for use in the United States, including considerations for testing and nPEP regimens ...

Human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) entails the prompt administration of antiretroviral agents following potential exposure to prevent viral acquisition. Clinical ...

Single-tablet therapy for HIV Researchers evaluated adherence to nonoccupational post-exposure prophylaxis following potential HIV exposure. A single-tablet regimen consisting of DOR/3TC/TDF for ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A brand new drug might be more effective at preventing HIV than current ...

The Health Service Executive (HSE) has introduced a new online assessment pathway to improve access to post-exposure prophylaxis (PEP) for people who may have had a recent exposure to HIV and cannot ...

Among individuals using HIV pre-exposure prophylaxis (HIV PrEP), doxycycline post-exposure prophylaxis (doxyPEP) was associated with a substantial decline in chlamydia and syphilis incidence.

A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, USA, ...

The Ministry of Health and Sanitation will from 1 July 2026 roll out Lenacapavir (LEN), a long-acting injectable HIV ...

Persons initiating nPEP should be informed that preexposure prophylaxis (PrEP) can reduce their risk for acquiring HIV in the case of repeat or continuing exposure after the nPEP course. HealthDay ...